Clinical Trial Update: Hydrocortisone for Prevention of Post-Traumatic Stress Disorder [NA]

View source ↗

Summary

The clinical trial evaluating hydrocortisone to prevent post-traumatic stress disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• HYDROCORTISONE (HYDROCORTISONE)

Snippet

Sponsor: Albert Einstein Healthcare Network | Conditions: Post-Traumatic Stress Disorder | NA | Status: WITHDRAWN